BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 29499439)

  • 1. Outcomes during anticoagulation in patients with symptomatic vs. incidental splanchnic vein thrombosis.
    Tufano A; Ageno W; Di Micco P; Niglio A; Rosa V; Ballaz A; Braester A; Rubio CM; Isern V; Imbalzano E; Monreal M;
    Thromb Res; 2018 Apr; 164():69-74. PubMed ID: 29499439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical course and treatment of incidentally detected splanchnic vein thrombosis: an individual patient data meta-analysis.
    Candeloro M; Valeriani E; Monreal M; Ageno W; Riva N; Schulman S; Bang SM; Mellado M; Díaz-Peromingo JA; Moisés J; Díaz-Brasero AM; Garcia-Pagan JC; Perez-Campuzano V; Senzolo M; De Gottardi A; Di Nisio M
    J Thromb Haemost; 2023 Jun; 21(6):1592-1600. PubMed ID: 36907381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulation and Vessel Recanalization in Cirrhotic Patients with Splanchnic Vein Thrombosis: A Multidisciplinary "Real Life" Experience.
    Rupoli S; Fiorentini A; Morsia E; Svegliati-Baroni G; Micucci G; Maroni L; Garvey KB; Fiorentini A; Riva A; Da Lio L; Benedetti A; Offidani M; Olivieri A; Giuseppe T
    Vasc Health Risk Manag; 2021; 17():619-629. PubMed ID: 34594107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation.
    Tzoran I; Papadakis M; Brenner B; Fidalgo Á; Rivas A; Wells PS; Gavín O; Adarraga MD; Moustafa F; Monreal M;
    Am J Med; 2017 Apr; 130(4):482.e1-482.e9. PubMed ID: 27986523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparisons Between Upper and Lower Extremity Deep Vein Thrombosis: A Review of the RIETE Registry.
    Cote LP; Greenberg S; Caprini JA; Tafur A; Choi C; Muñoz FJ; Skride A; Valero B; Porras JA; Ciammaichella M; Hernández-Blasco LM; Monreal M;
    Clin Appl Thromb Hemost; 2017 Oct; 23(7):748-754. PubMed ID: 27572888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender-related differences in the outcome of patients with venous thromboembolism and thrombophilia.
    Tzoran I; Papadakis E; Brenner B; Valle R; López-Jiménez L; García-Bragado F; Riera-Mestre A; Villalobos A; Quintavalla R; Monreal M;
    Thromb Res; 2017 Mar; 151 Suppl 1():S11-S15. PubMed ID: 28262227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous thromboembolism in centenarians: Findings from the RIETE registry.
    Lacruz B; Tiberio G; Núñez MJ; López-Jiménez L; Riera-Mestre A; Tiraferri E; Verhamme P; Mazzolai L; González J; Monreal M;
    Eur J Intern Med; 2016 Dec; 36():62-66. PubMed ID: 27495947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulant therapy for venous thromboembolism in patients with inflammatory bowel disease.
    Lobo JL; Garcia-Fuertes JA; Trujillo-Santos J; Merah A; Blanco-Molina MÁ; Casado I; Hirmerova J; De Miguel J; Salgado E; Monreal M;
    Eur J Gastroenterol Hepatol; 2018 May; 30(5):526-530. PubMed ID: 29462026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venous Thromboembolism in Patients With Autoimmune Disorders: Findings From the RIETE Registry.
    Sada PR; López-Núñez JJ; Samperiz A; Soto MJ; Pedrajas JM; Porras JA; Peris ML; Olivé A; Debourdeau P; Pace F; Monreal M;
    Angiology; 2020 Feb; 71(2):131-138. PubMed ID: 31578072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subsequent arterial ischemic events in patients receiving anticoagulant therapy for venous thromboembolism.
    Madridano O; del Toro J; Lorenzo A; Martín M; Gómez Cerezo J; Hernández L; Prandoni P; Monreal M;
    J Vasc Surg Venous Lymphat Disord; 2015 Apr; 3(2):135-41.e1. PubMed ID: 26993830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term Clinical Outcomes of Splanchnic Vein Thrombosis: Results of an International Registry.
    Ageno W; Riva N; Schulman S; Beyer-Westendorf J; Bang SM; Senzolo M; Grandone E; Pasca S; Di Minno MN; Duce R; Malato A; Santoro R; Poli D; Verhamme P; Martinelli I; Kamphuisen P; Oh D; D'Amico E; Becattini C; De Stefano V; Vidili G; Vaccarino A; Nardo B; Di Nisio M; Dentali F
    JAMA Intern Med; 2015 Sep; 175(9):1474-80. PubMed ID: 26168152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-life treatment of venous thromboembolism with direct oral anticoagulants: The influence of recommended dosing and regimens.
    Trujillo-Santos J; Di Micco P; Dentali F; Douketis J; Díaz-Peromingo JA; Núñez MJ; Cañas I; Mastroiacovo D; Saraiva de Sousa M; Monreal M;
    Thromb Haemost; 2017 Jan; 117(2):382-389. PubMed ID: 27786333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulant therapy for splanchnic vein thrombosis: an individual patient data meta-analysis.
    Candeloro M; Valeriani E; Monreal M; Ageno W; Riva N; Lopez-Reyes R; Peris ML; Beyer Westendorf J; Schulman S; Rosa V; López-Núñez JJ; Garcia-Pagan JC; Magaz M; Senzolo M; De Gottardi A; Di Nisio M
    Blood Adv; 2022 Aug; 6(15):4516-4523. PubMed ID: 35613465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulant Treatment for Splanchnic Vein Thrombosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis.
    Valeriani E; Di Nisio M; Riva N; Cohen O; Porreca E; Senzolo M; De Gottardi A; Magaz M; Garcia-Pagan JC; Ageno W
    Thromb Haemost; 2021 Jul; 121(7):867-876. PubMed ID: 33525037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of long-term anticoagulant treatment for the secondary prophylaxis of splanchnic venous thrombosis.
    Serrao A; Merli M; Lucani B; Aprile F; Fiori L; Gioia S; Breccia M; Riggio O; Chistolini A
    Eur J Clin Invest; 2021 Jan; 51(1):e13356. PubMed ID: 33180323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer: A Randomized Clinical Trial.
    Lee AYY; Kamphuisen PW; Meyer G; Bauersachs R; Janas MS; Jarner MF; Khorana AA;
    JAMA; 2015 Aug; 314(7):677-686. PubMed ID: 26284719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Splanchnic vein thrombosis].
    Lajzová S; Kroupa R; Buliková A; Bohatá Š; Packová B; Šenkyřík M
    Vnitr Lek; 2018; 64(3):272-279. PubMed ID: 29766730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulant therapy for splanchnic vein thrombosis: a systematic review and meta-analysis.
    Valeriani E; Di Nisio M; Riva N; Cohen O; Garcia-Pagan JC; Magaz M; Porreca E; Ageno W
    Blood; 2021 Mar; 137(9):1233-1240. PubMed ID: 32911539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superficial vein thrombosis and recurrent venous thromboembolism: a pooled analysis of two observational studies.
    Galanaud JP; Bosson JL; Genty C; Presles E; Cucherat M; Sevestre MA; Quere I; Decousus H; Leizorovicz A
    J Thromb Haemost; 2012 Jun; 10(6):1004-11. PubMed ID: 22429908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Outcome of Splanchnic Vein Thrombosis in Cirrhosis.
    Senzolo M; Riva N; Dentali F; Rodriguez-Castro K; Sartori MT; Bang SM; Martinelli I; Schulman S; Alatri A; Beyer-Westendorf J; Di Minno MND; Ageno W;
    Clin Transl Gastroenterol; 2018 Aug; 9(8):176. PubMed ID: 30108204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.